Close Menu

Stanford

The team integrated tumor barcoding, genome editing, and ultra-deep barcode sequencing to interrogate pairwise combinations of tumor suppressor alterations.

Retraction Watch reports that the Nature Methods paper finding off-target effects of the CRISPR/Cas9 gene-editing machinery has been retracted.

Sample Ethics

The authors of and the journal that published the sequencing study of the Atacama skeleton have responded to concerns over how the sample was obtained.

Mutations identified in DNA from the infant's skeleton were linked to bone disorders, including scoliosis, dwarfism, and skeletal dysplasia.

A new study in JAMA finds that genetic tests might not be able to determine what diet is right for someone seeking to lose weight.

In Nucleic Acids Research this week: structure diversity of alphavirus genomes, assay for detecting SNPs using sequencing-based mismatch detection clues, and more.

In Cell this week: somatic cell nuclear transfer cloning of macaques, high-resolution yeast causal variant map, and more.

The partners are working together to build a registry of genetic and other data for a study of sleep in more than 30,000 individuals.

Following some major integration issues and other data challenges, Stanford is preparing to expand genomic medicine beyond rare diseases and cancer.

Its CEO said that although a hospital screening test for sepsis is a focus, a fever test that informs about antibiotic use could be available sooner.

Pages

A man has confessed to the rape and murder of developmental biologist Suzanne Eaton, according to the New York Times.

The Irish Times reports that US lawmakers and law enforcement agencies are concerned about ties between the US and Chinese genomics firms.

Parents of children with spinal muscular atrophy tell the Washington Post they are pushing to get insurance coverage of Novartis's Zolgensma.

In PNAS this week: gene mutations in individuals with syndromic craniosynostosis, putative colorectal cancer drivers, and more.